
Oncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
Hematologic Oncology Update
00:00
Venetoclax and Relapse
I wasn't even aware that the PFS was different. Matt David's actually has a study that has launched and I think they've accrued a few patients. They are systematically asking this question where they're taking patients who are treated with classic Venetoclax, Obenetu's med previously,. Who then relapse, but there is no other option. The issue is I've been using this combination for quite some time on clinical trials. My first patient that I treated in 2016 has just now relapsed.
Transcript
Play full episode